Jeff Wang said: “We wish to see Christoph Hummel recover as soon as possible. However, the current industry situation is so tense that we do not want to leave the crucial position of CEO vacant during Mr. Hummel’s absence. We are delighted that Dr. Michael Roesnick has agreed to this interim solution and are convinced that we have found the ideal team which will benefit the company.”
“The most important thing at the moment is that Mr. Hummel will recover as soon as possible,” said Dr. Michael Roesnick. “While I no longer intended to take on such an active management role, I would like to help the company, which is very close to my heart, in the best possible way, and I look forward to working with the Preh team.”